Patient eligibility for highly specialised drugs.
An eligible patient:
- is, or is to be treated as, an eligible person within the meaning of the Health Insurance Act 1973 (the Act), and
- receiving appropriate specialist medical treatment by an approved prescriber, or from a hospital as:
- a non-admitted patient
- a day admitted patient, or
- a patient on discharge
An eligible person is defined by the Act as one of the following:
- an Australian resident
- a person covered by a Reciprocal Health Care Agreement (RHCA), or
- an eligible overseas representative
An Australian resident is a person who resides permanently in Australia and is one of the following:
- an Australian citizen
- a person who holds a permanent visa
- a New Zealand citizen, or
- an applicant for permanent residence in certain circumstances - not a parent applicant who has a valid visa with permission to work or has a parent, spouse or child who is an Australian citizen or holds permanent resident status with an interim Medicare card
Eligible overseas representative means:
- the head of a diplomatic mission or consular post, established in Australia, of those countries with which Australia has an Reciprocal Health Care Agreement except for New Zealand and Norway
- staff of those diplomatic missions or consular posts, or
- family members of heads or staff of those diplomatic missions or consular posts
Eligible overseas persons will have a Medicare card.
An eligible person who has enrolled in Medicare and has not yet received their card can use their Medicare card receipt with their Medicare number printed on it as evidence of eligibility.
Reciprocal Health Care Agreement
If a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.
Read more about Reciprocal Health Care Agreements.
All eligible patients need to pay a contribution fee for each supply of PBS or Repatriation Pharmaceutical Benefits Scheme (RPBS) HSDs. The fee may be general, concessional or an entitlement.